PharmExec Global Marketing:
Having trouble viewing this e-mail? Click here.
PharmExec Direct | From the editors of Pharmaceutical Executive
Send Us Some Feedback
| Advertise With Us | Visit PharmExec.com |
PRINT SUBSCRIBE | DIGITAL SUBSCRIBE
August 26, 2015 | ISSUE NUMBER 24 VOL 1
Top Story
Time for a Wearable Strategy
Analysts are saying that more than 4 million Apple Watches were sold in the Q2 2015, grabbing up to 75 percent of the smartwatch market, way ahead of nearest rival Samsung. This continuing rise of wearable technology is thanks in particular to health and fitness applications. Peter Houston reports
...Read more
Pharmaceutical Executive E-Book – Coming November 2015: Securing the Global Supply Chain: Strategies for Operational Excellence
Key Topics include:
- Compliance Groundswell: What are the New Rules and Regulator Expectations?
- Global Dynamics of Risk: Can Technology Keep Pace?
- Benchmarking Best Practices: Upgrading Company Performance Culture
- What’s Ahead: How Logistics and Distribution Science will Shape Tomorrow's Supply Chain
Contact your sales rep for more information and to secure your sponsorship
Comment
Pharma Must Move Beyond Cooperation to True Collaboration
We hear a lot about the need for pharma companies to collaborate. But while pharmacos appreciate the need to work together, organizations are still misdirecting their efforts into co-operation and co-ordination, writes Mike Straw ...Read more
Pharmaceutical Executive E-Book – Coming October 2015: Changing Contours of Commercialization: Impact of US Health Reform on Patients, Payers and Providers
Key Topics include:
- Phase-in of the 2010 Affordable Care Act: Five stages of pain and plenty
- Pay for Performance and Shared Savings Programs – Implications for Pharma Marketers
- How ACO models are driving physician and provider decision-making
- Primer on policies and financial drivers impacting payer markets – MLR, MSSP, CMS etc.
Contact your sales rep for more information and to secure your sponsorship
Pricing
New Payment Models: It's Time to Move
Fundamental changes in the US access and reimbursement landscape are accelerating for the vast majority of public and commercial stakeholders. Commercial success for pharma brands now demands proactive strategies and interventions, writes Stacie Heller and Peter Weissberg
...Read more
On the road to integration
Moving your multichannel program into the fast lane

On Demand
Join Peter Lammers and Liz Murray from Quintiles as they present insightful research findings regarding the state of the pharmaceutical industry and the use of multi-channel marketing strategies. Learn what other industries apply successfully and get different options for you to actually "make it happen" for your product.
Learn More
Recruitment
Attracting the Ideal Millennial Workforce
The key to success in the modern pharma era is engaging a workforce that's flexible enough to keep pace with evolving needs. That's where contingent labor comes in, writes Rebecca Cenni
...Read more
Breaking through the complexity
Improving oncology treatment and access in the UK

On Demand
Join Dean Summerfield, Senior Vice President, Commercial and Consulting from Quintiles and Dr Jason Lester, Consultant Clinical Oncologist at the Velindre Cancer Centre as they discuss improving innovative oncology treatment and access in the UK.
Learn More
Europe
The “Seasoned Biotech CEO”: A Rare Commodity
A recent survey of European biopharma companies and board members revealed that 80 percent of firms find access to qualified senior executives to be a challenge, with the toughest spot to fill being the “seasoned CEO”
...Read more
Patient adherence in Germany - benefit vs. cost-containment
On Demand
Join Joanne Thiele, Market Access Project Manager from Quintiles Germany and Hans Holger Bleβ, Director of Health Services Research department at IGES Institut GmbH as they discuss the importance of patient adherence programs in Germany.
Learn More
//GenoSpace (Cambridge, MA) appointed Matthew Fischer as Vice President, Sales & Marketing.//Google’s healthcare advisory board has selected Monique Levy, Vice President of Digital Innovation at Decision Resources Group (Burlington, MA), to join its team.//Sudler & Hennessey Group UK (London, UK) appointed Mark Boulding as Director of Strategy, Jason Galla-Barth as Head of Digital and Abbie Pound as Head of Medical Communications. //Merck KGaA (Darmstadt, Germany) has selected Isabel De Paoli as its new Head of Group Communications to take over from Walter Huber, who is set to retire in March 2016.//
September 17–18: Immunotherapy Commercialization
Boston, MA.


December 2–3: Publication Planning
Philadelphia, PA.


January 28–29, 2016: 11th Summit on Biosimilars
Alexandria, VA.


February 23–24, 2016: Oncology Commercialization and Market Access
San Francisco, CA.



 
Follow Pharm Exec on Twitter
Follow Pharm Exec on Linkedin



Quick Links
Pharm Exec’s 2015 Emerging Pharma Leaders

Pharm Exec’s Top 50 Pharma Companies

Polling Question: Would You Move to Another Continent for a Leadership Position?

Pharm Exec eBooks Availabe as Apps